0001595585-21-000018.txt : 20210115 0001595585-21-000018.hdr.sgml : 20210115 20210115163202 ACCESSION NUMBER: 0001595585-21-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210113 FILED AS OF DATE: 20210115 DATE AS OF CHANGE: 20210115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLAERNER GERRIT CENTRAL INDEX KEY: 0001743681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38558 FILM NUMBER: 21532490 MAIL ADDRESS: STREET 1: C/O TRICIDA, INC. STREET 2: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tricida, Inc. CENTRAL INDEX KEY: 0001595585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463372526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-429-7800 MAIL ADDRESS: STREET 1: 7000 SHORELINE COURT, SUITE 201 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 wf-form4_161074630769056.xml FORM 4 X0306 4 2021-01-13 0 0001595585 Tricida, Inc. TCDA 0001743681 KLAERNER GERRIT 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Common Stock 2021-01-13 4 S 0 15035 7.41 D 509648 D Common Stock 2021-01-14 4 S 0 1655 7.18 D 507993 D Common Stock 25323 I By Spouse The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.22 to $7.63, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.06 to $7.32, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The shares were awarded to the reporting person's spouse in connection with independent services provided by the spouse to Tricida, Inc. /s/ Geoffrey M. Parker, attorney-in-fact 2021-01-15